EUVIMEDEUVIMED entdecken
Crossref

Mitochondrial Disruption Nanosystem Simultaneously Depressed Programmed Death Ligand-1 and Transforming Growth Factor-β to Overcome Photodynamic Immunotherapy Resistance

Xin Jiang, Lei Yi, Cheng Li, Haoxiang Wang, Wei Xiong, Yuan Li, Zaigang Zhou, Jianliang Shen iD

ACS Nano · 2024

DOI: 10.1021/acsnano.3c10117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Xin Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China. Hauptthemen laut MEDLINE: B7-H1 Antigen, Lung Neoplasms. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Wenzhou Medical University, Natural Science Foundation of??Hunan Province, Science Fund for Distinguished Young Scholars of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenLung NeoplasmsHumansTransforming Growth Factor betaLigandsProteomicsImmunotherapyMitochondriaTransforming Growth FactorsTumor MicroenvironmentCell Line, Tumor

Stichwörter der Autor:innen

Mitochondria metabolism regulationPhotodynamic immunotherapyProgrammed death ligand-1TamoxifenTransforming growth factor-β

Substanzen

B7-H1 AntigenTransforming Growth Factor betaLigandsTransforming Growth Factors

Autor:innen und Institutionen

  • Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China.
  • Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China.
  • Zhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325001, China.

ORCID-Profile: Jianliang Shen

Förderung

  • Wenzhou Medical University
  • Natural Science Foundation of??Hunan Province
  • Science Fund for Distinguished Young Scholars of Zhejiang Province
  • National Natural Science Foundation of China
  • Zhejiang Qianjiang Talent Plan

Zitieren

APA

Jiang, X., Yi, L., Li, C., Wang, H., Xiong, W., Li, Y., Zhou, Z., & Shen, J. (2024). Mitochondrial Disruption Nanosystem Simultaneously Depressed Programmed Death Ligand-1 and Transforming Growth Factor-β to Overcome Photodynamic Immunotherapy Resistance. ACS Nano. https://doi.org/10.1021/acsnano.3c10117

Vancouver

Jiang X, Yi L, Li C, Wang H, Xiong W, Li Y, et al. Mitochondrial Disruption Nanosystem Simultaneously Depressed Programmed Death Ligand-1 and Transforming Growth Factor-β to Overcome Photodynamic Immunotherapy Resistance. ACS Nano. 2024. doi:10.1021/acsnano.3c10117

BibTeX
@article{Jiang2024,
  author = {Jiang, Xin and Yi, Lei and Li, Cheng and Wang, Haoxiang and Xiong, Wei and Li, Yuan and Zhou, Zaigang and Shen, Jianliang},
  title = {Mitochondrial Disruption Nanosystem Simultaneously Depressed Programmed Death Ligand-1 and Transforming Growth Factor-β to Overcome Photodynamic Immunotherapy Resistance},
  journal = {ACS Nano},
  year = {2024},
  doi = {10.1021/acsnano.3c10117}
}
Kostenlos starten →